CDKN2A and cancer: Interestingly, a decrease in dietary folate intake induces methylation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which improves tumorigenesis and metastasis with cancer recurrence and poor prognosis; this relationship is modified by the methylenetetrahydrofolate reductase (MTHFR) genotype [116].